Gastric bypass increases postprandial insulin and GLP-1 in nonobese minipigs

European Surgical Research

Volumn 52, Issue 1-2, 2014, Pages 41-49

  Verhaeghe, R ^a,b   Zerrweck, C ^a,b   Hubert, T ^b,c   Trechot B ^b   Gmyr, V ^b,c   D'Herbomez, M ^a   Pigny, P ^a   Pattou, F ^a,b,c   Caiazzo, R ^a,b,c  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c France   (France)

Author keywords

Animal model; Bariatric surgery; Diabetes; GLP 1; Incretin; Metabolic surgery; Minipig; Roux en Y gastric bypass

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; XYLOSE; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ARTICLE; CARBOHYDRATE ABSORPTION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; MINIPIG; NONHUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; STOMACH BYPASS; ABSORPTION; ADULT; BARIATRIC SURGERY; BODY WEIGHT; DIGESTIVE SYSTEM; GOTTINGEN MINIPIG; HORMONE RELEASE; LEAN BODY WEIGHT; ROUX EN Y GASTRIC BYPASS; ROUX Y ANASTOMOSIS; STOMACH POUCH; TEST MEAL; ANIMAL; ANIMAL MODEL; AUDIOVISUAL EQUIPMENT; BLOOD; DIABETES MELLITUS, TYPE 2; HUMAN; METABOLISM; OBESITY; PHYSIOLOGY; PIG;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; MODELS, ANATOMIC; MODELS, ANIMAL; OBESITY; POSTPRANDIAL PERIOD; SWINE; SWINE, MINIATURE; XYLOSE;

EID: 84895644825     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000355678     Document Type: Article

References (36)

1. Buchwald H, Estok R, Fahrbach K, et al: Weight and type 2 diabetes after bariatric surgery: systematic reviewand meta-analysis. Am J Med 2009; 122: 248-256.e5.
2. Pories WJ, Caro JF, Flickinger EG, Meelheim HD, Swanson MS: The control of diabetes mellitus (NIDDM) in themorbidly obese with the Greenville Gastric Bypass. Ann Surg 1987; 206: 316-323.
3. Holst JJ: The physiology of glucagon-like peptide 1. Physiol Rev 2007; 87: 1409-1439.
4. Cummings DE, Overduin J, Foster-Schubert KE: Gastric bypass for obesity: mechanisms of weight loss anddiabetes resolution. J Clin Endocrinol Metab 2004; 89: 2608-2615.
5. Kazafeos K: Incretin effect: GLP-1, GIP, DPP4. Diabetes Res Clin Pract 2011; 93(suppl 1):S32-S36.
6. Vidal J, Nicolau J, Romero F, et al: Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagonlikepeptide-1 and islet function in morbidly obese subjects. J Clin Endocrinol Metab 2009; 94: 884-891.
7. Laferrère B, Teixeira J, McGinty J, et al: Effect of weight loss by gastric bypass surgery versus hypocaloric dieton glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 2479-2485.
8. Rao RS, Rao V, Kini S: Animal models in bariatric surgery-a review of the surgical techniques and postsurgicalphysiology. Obes Surg 2010; 20: 1293-1305.
9. Larsen MO, Rolin B, Wilken M, Carr RD, Gotfredsen CF: Measurements of insulin secretory capacity and glucosetolerance to predict pancreatic beta-cell mass in vivo in the nicotinamide/streptozotocin Göttingen minipig,a model of moderate insulin deficiency and diabetes. Diabetes 2003; 52: 118-123.
10. Larsen MO, Rolin B: Use of the Göttingen minipig as a model of diabetes, with special focus on type 1 diabetesresearch. ILAR J 2004; 45: 303-313.
11. Dolgin E: Minipig, minipig, let me in. Nature Medicine 2010; 16: 1349.
12. Flum DR, Devlin A, Wright AS, et al: Development of a porcine Roux-en-Y gastric bypass survival model for thestudy of post-surgical physiology. Obes Surg 2007; 17: 1332-1339.
13. Dar MS, Chapman WH 3rd, Pender JR, et al: GLP-1 response to a mixed meal: what happens 10 years afterRoux-en-Y gastric bypass (RYGB)? Obes Surg 2012; 22: 1077-1083.
14. Morínigo R, Moizé V, Musri M, et al: Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastricbypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2006; 91: 1735-1740.
15. Laferrère B: Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes (Lond) 2011; 35(suppl3):S22-S25.
16. Rubino F, Marescaux J: Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: anew perspective for an old disease. Ann Surg 2004; 239: 1-11.
17. Geloneze B, Geloneze SR, Fiori C, et al: Surgery for nonobese type 2 diabetic patients: an interventional studywith duodenal-jejunal exclusion. Obesity Surgery 2009; 19: 1077-1083.
18. Patriti A, Facchiano E, Annetti C, et al: Early improvement of glucose tolerance after ileal transposition in anon-obese type 2 diabetes rat model. Obes Surg 2005; 15: 1258-1264.
19. Boza C, Muñoz R, Yung E, Milone L, Gagner M: Sleeve gastrectomy with ileal transposition (SGIT) induces asignificant weight loss and diabetes improvement without exclusion of the proximal intestine. J GastrointestSurg 2011; 15: 928-934.
20. Wang TT, Hu SY, Gao HD, et al: Ileal transposition controls diabetes as well as modified duodenal jejunalbypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg2008; 247: 968-975.
21. Toft-Nielsen MB, Damholt MB, Madsbad S, et al: Determinants of the impaired secretion of glucagon-likepeptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 2001; 86: 3717-3723.
22. Carr RD, Larsen MO, Jelic K, et al: Secretion and dipeptidyl peptidase 4-mediated metabolism of incretinhormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men. J Clin EndocrinolMetab 2010; 95: 872-878.
23. Xu Y, Ohinata K, Meguid MM, et al: Gastric bypass model in the obese rat to study metabolic mechanisms ofweight loss. J Surg Res 2002; 107: 56-63.
24. Fried M, Ribaric G, Buchwald JN, et al: Metabolic surgery for the treatment of type 2 diabetes in patients withBMI
25. Huang CK, Shabbir A, Lo CH, et al: Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetesmellitus in Chinese patients with body mass index of 25-35. Obes Surg 2011; 21: 1344-1349.
26. Potvin M, Gagner M, Pomp A: Laparoscopic Roux-en-Y gastric bypass for morbid obesity: a feasibility study inpigs. Surg Laparosc Endosc 1997; 7: 294-297.
27. Cagigas JC, Martino E, Escalante CF, et al: Technical alternatives in laparoscopic distal gastric bypass formorbid obesity in a porcine model. Obes Surg 1999; 9: 166-170.
28. Scott DJ, Provost DA, Tesfay ST, Jones DB: Laparoscopic Roux-en-Y gastric bypass using the porcine model.Obes Surg 2001; 11: 46-53.
29. Brackman MR, Finelli FC, Light T, et al: Helium pneumoperitoneum ameliorates hypercarbia and acidosis associatedwith carbon dioxide insufflation during laparoscopic gastric bypass in pigs. Obes Surg 2003; 13: 768-771.
30. Kim WW, Gagner M, Biertho L, Waage A, Jacob B: Taking posterior rectus sheath laparoscopically to reinforcethe gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass. Obes Surg 2003; 13: 258-262.
31. Waage A, Gagner M, Biertho L, et al: Comparison between open hand-sewn, laparoscopic stapled and laparoscopiccomputer-mediated, circular stapled gastro-jejunostomies in Roux-en-Y gastric bypass in the porcinemodel. Obes Surg 2005; 15: 782-787.
32. Nocca D, Gagner M, Abente FC, et al: Laparoscopic gastric bypass with silicone band in a pig model: preventionof anastomotic dilatation-feasibility study. Obes Surg 2005; 15: 523-527.
33. Gentileschi P, Gagner M, Milone L, Kini S, Fukuyama S: Histologic studies of the bypassed stomach after Rouxen-Y gastric bypass in a porcine model. Obes Surg 2006; 16: 886-890.
34. Kiciak A, Woliñski J, Borycka K, Zabielski R, Bielecki K: Roux-en-Y or 'uncut' Roux procedure? Relation of intestinalmigrating motor complex recovery to the preservation of the network of interstitial cells of Cajal in pigs.Exp Physiol 2007; 92: 399-408.
35. Manson RJ, Pryor AD: Bipolar sealing increases mesenteric reach during bowel transection compared withstapled division: clinical evidence and laboratory support in a porcine model. Surg Endosc 2008; 22: 1894-1898.
36. Escareno CE, Azagury DE, Flint RS, et al: Establishing a reproducible large animal survival model of laparoscopicRoux-en-Y gastric bypass. Surg Obes Relat Dis 2012; 8: 764-769.